<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100892858</journal-id>
<journal-id journal-id-type="pubmed-jr-id">30235</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsy Behav</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsy Behav</journal-id>
<journal-title-group>
<journal-title>Epilepsy &amp; behavior : E&amp;B</journal-title>
</journal-title-group>
<issn pub-type="ppub">1525-5050</issn>
<issn pub-type="epub">1525-5069</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29097123</article-id>
<article-id pub-id-type="pmc">5756681</article-id>
<article-id pub-id-type="doi">10.1016/j.yebeh.2017.09.016</article-id>
<article-id pub-id-type="manuscript">NIHMS909068</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epilepsy as a network disorder: What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Scharfman</surname>
<given-names>Helen E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<!--<email>hscharfman@nki.rfmh.org</email>-->
<!--<email>helen.scharfman@nyumc.org</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanner</surname>
<given-names>Andres M.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Friedman</surname>
<given-names>Alon</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blumcke</surname>
<given-names>Ingmar</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crocker</surname>
<given-names>Candice E.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cendes</surname>
<given-names>Fernando</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diaz-Arrastia</surname>
<given-names>Ramon</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Förstl</surname>
<given-names>Hans</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fenton</surname>
<given-names>André A.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grace</surname>
<given-names>Anthony A.</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palop</surname>
<given-names>Jorge</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrison</surname>
<given-names>Jason</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nehlig</surname>
<given-names>Astrid</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prasad</surname>
<given-names>Asuri</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilcox</surname>
<given-names>Karen S.</given-names>
</name>
<xref ref-type="aff" rid="A15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jette</surname>
<given-names>Nathalie</given-names>
</name>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pohlmann-Eden</surname>
<given-names>Bernd</given-names>
</name>
<xref ref-type="aff" rid="A17">17</xref>
<!--<email>B.Pohlmann-Eden@dal.ca</email>-->
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Professor of Child &amp; Adolescent Psychiatry, Neuroscience &amp; Physiology and Psychiatry, and Investigator, Neuroscience Institute, New York University Langone Medical Center New York, NY 10016 and The Nathan Kline Institute, Orangeburg, NY, USA</aff>
<aff id="A2">
<label>2</label>Professor of Clinical Neurology, University of Miami, Miller School of Medicine 1120 NW 14<sup>th</sup> Street, Room #1324, Miami, FL, 33136, USA</aff>
<aff id="A3">
<label>3</label>Professor of Neuroscience, Dennis Chair in Epilepsy Research, Departments of Medical Neuroscience and Pediatrics, Faculty of Medicine, Dalhousie University Halifax, NS, Canada, and Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel</aff>
<aff id="A4">
<label>4</label>Director Neuropathological Institute, University Hospitals Erlangen, Germany</aff>
<aff id="A5">
<label>5</label>Nova Scotia Early Psychosis Program, Department of Psychiatry, Dalhousie University, Halifax, NS, Canada</aff>
<aff id="A6">
<label>6</label>Professor and Chair, Department of Neurology, University of Campinas, 13083-888 Campinas, Sao Paulo, Brazil</aff>
<aff id="A7">
<label>7</label>Director of Clinical Research, Centre for Neuroscience &amp; Regenerative Medicine Professor of Neurology, Uniformed Services University of the Health Sciences 12725 Twinbrook Parkway, Rockville, MD 20852, USA</aff>
<aff id="A8">
<label>8</label>Professor, Chair, Department of Psychiatry, University of Munich, Klinikum rechts der Isar, Ismaninger Strabe 22, D-81675 Munich, Germany</aff>
<aff id="A9">
<label>9</label>Professor of Neural Sciences, Centre for Neural Science, New York University, 4 Washington Place, Room 809, New York, NY 10003, USA</aff>
<aff id="A10">
<label>10</label>Distinguished Professor of Neuroscience, Professor of Psychiatry &amp; Psychology, University of Pittsburgh, 456 Langley Hall, 4200 Fifth Avenue, Pittsburgh, PA 15269, USA</aff>
<aff id="A11">
<label>11</label>Gladstone Institute of Neurological Disease, Department of Neurology, Gladstone Institute1650 Owens Street, San Francisco, CA 94158-2261, USA</aff>
<aff id="A12">
<label>12</label>Department of Psychiatry, Dalhousie University, Halifax, NS, Canada</aff>
<aff id="A13">
<label>13</label>INSERM U 1129, Hôpital Necker, Paris, Faculty of Medicine, Strasbourg, France</aff>
<aff id="A14">
<label>14</label>Professor in Pediatrics &amp; Clinical Neurosciences, Department of Pediatrcs Children’s Hospital of Western Ontario, London, ON, Canada</aff>
<aff id="A15">
<label>15</label>Professor and Chair, Department of Pharmacology &amp; Toxicology, Director, Anticonvulsant Drug Development Program, University of Utah Salt Lake City, Utah, USA</aff>
<aff id="A16">
<label>16</label>Icahn School of Medicine at Mount Sinai, Department of Neurology, New York, NY and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta</aff>
<aff id="A17">
<label>17</label>Bernd Pohlmann-Eden, Professor of Neurology, Brain Repair Center, Life Science Research Institute, Dalhousie University, Room 229, PO Box 15000, Halifax, Nova Scotia, B3H4R2, Canada</aff>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>78</volume>
<fpage>302</fpage>
<lpage>312</lpage>
<!--elocation-id from pubmed: 10.1016/j.yebeh.2017.09.016-->
<abstract>
<p id="P2">There is common agreement that many disorders of the central nervous system are ‘complex’ meaning that there are many potential factors that influence the development of the disease, underlying mechanisms and successful treatment. Most of these disorders, unfortunately, have no cure at the present time and therapeutic strategies often have debilitating side effects. Interestingly, some of the ‘complexities’ of one disorder are found in another, and the similarities are often network defects. It seems likely that more discussion of these commonalities could advance our understanding and therefore have clinicial implications or translational impact. With this in mind, the Fourth International Halifax Epilepsy Conference and Retreat was held as described in the prior paper, and this companion paper focuses on the second half of the meeting. Leaders in varies subspecialities of epilepsy research were asked to address Aging and Dementia or Psychosis in people with epilepsy (PWE). Commonalities between Autism, Depression, Aging and Dementia, Psychosis, and Epilepsy were the focus of the presentations and discussion. In the last session, additional experts commented on new conceptualization of translational epilepsy research efforts. Here the presentations are reviewed and salient points are highlighted.</p>
</abstract>
<kwd-group>
<kwd>seizure</kwd>
<kwd>Alzheimer’s disease</kwd>
<kwd>psychosis</kwd>
<kwd>preclinical</kwd>
<kwd>circuit</kwd>
<kwd>systems</kwd>
<kwd>neuroscience</kwd>
<kwd>neurology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>